← Back to Clinical Trials
Recruiting NCT07744438

NCT07744438 45 V vs 60 V Pulsed Radiofrequency of the Cervical Dorsal Root Ganglion for Cervical Radicular Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07744438
Status Recruiting
Phase
Sponsor Ankara Etlik City Hospital
Condition Cervical Radicular Pain
Study Type INTERVENTIONAL
Enrollment 58 participants
Start Date 2026-07-29
Primary Completion 2027-02-26

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
45 V cervical dorsal root ganglion pulsed radiofrequency60 V cervical dorsal root ganglion pulsed radiofrequency

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 58 participants in total. It began in 2026-07-29 with a primary completion date of 2027-02-26.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to compare the clinical outcomes of 45 V and 60 V pulsed radiofrequency (PRF) applied to the cervical dorsal root ganglion (DRG) in patients with cervical radicular pain. Treatment efficacy will be evaluated using the Numerical Rating Scale (NRS) for pain intensity and the Neck Disability Index (NDI) for functional disability. Procedure-related adverse events will also be compared to assess the safety of both voltage settings.

Eligibility Criteria

Inclusion Criteria: * Unilateral cervical radicular pain consistent with cervical disc herniation. * Pain intensity of ≥6 on the Numerical Rating Scale (NRS). * Radicular pain persisting for at least 3 months. * MRI evidence of lower cervical nerve root compression consistent with clinical findings. * Inadequate response to conservative treatment, including analgesic medications and physical therapy. * Completion of cervical dorsal root ganglion pulsed radiofrequency (PRF) treatment. Exclusion Criteria: * Bilateral upper extremity pain or predominant axial neck pain. * Cervical spinal stenosis, spondylolisthesis, cervical myelopathy, or other structural spinal disorders causing radicular pain. * Previous cervical spine surgery at the target level. * Cognitive impairment preventing reliable outcome assessment. * Active local or systemic infection. * Coagulopathy or inability to discontinue anticoagulant/antiplatelet therapy for the procedure. * Severe hepatic or renal failure. * Pregnancy. * Unstable psychiatric disorders. * Any condition that could interfere with completion of follow-up evaluations.

Contact & Investigator

Central Contact

Gokhan Yildiz

✉ gkoyldz@gmail.com

📞 5059272589

Principal Investigator

Gokhan Yildiz

PRINCIPAL INVESTIGATOR

Ankara Etlik City Hospital

Frequently Asked Questions

Who can join the NCT07744438 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Cervical Radicular Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07744438 currently recruiting?

Yes, NCT07744438 is actively recruiting participants. Contact the research team at gkoyldz@gmail.com for enrollment information.

Where is the NCT07744438 trial being conducted?

This trial is being conducted at Ankara, Turkey (Türkiye).

Who is sponsoring the NCT07744438 clinical trial?

NCT07744438 is sponsored by Ankara Etlik City Hospital. The principal investigator is Gokhan Yildiz at Ankara Etlik City Hospital. The trial plans to enroll 58 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology